IBDEI1ZT ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33816,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,33816,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,33816,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,33817,0)
 ;;=I07.1^^131^1679^21
 ;;^UTILITY(U,$J,358.3,33817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33817,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,33817,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,33817,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,33818,0)
 ;;=I07.9^^131^1679^22
 ;;^UTILITY(U,$J,358.3,33818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33818,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,33818,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,33818,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,33819,0)
 ;;=I08.0^^131^1679^16
 ;;^UTILITY(U,$J,358.3,33819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33819,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,33819,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,33819,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,33820,0)
 ;;=I09.89^^131^1679^17
 ;;^UTILITY(U,$J,358.3,33820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33820,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,33820,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,33820,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,33821,0)
 ;;=I47.1^^131^1679^24
 ;;^UTILITY(U,$J,358.3,33821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33821,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,33821,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,33821,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,33822,0)
 ;;=I48.0^^131^1679^15
 ;;^UTILITY(U,$J,358.3,33822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33822,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,33822,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,33822,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,33823,0)
 ;;=I49.5^^131^1679^23
 ;;^UTILITY(U,$J,358.3,33823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33823,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,33823,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,33823,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,33824,0)
 ;;=I49.8^^131^1679^3
 ;;^UTILITY(U,$J,358.3,33824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33824,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,33824,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,33824,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,33825,0)
 ;;=I49.9^^131^1679^2
 ;;^UTILITY(U,$J,358.3,33825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33825,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,33825,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,33825,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,33826,0)
 ;;=R00.1^^131^1679^1
 ;;^UTILITY(U,$J,358.3,33826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33826,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,33826,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,33826,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,33827,0)
 ;;=I34.1^^131^1679^14
 ;;^UTILITY(U,$J,358.3,33827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33827,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,33827,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,33827,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,33828,0)
 ;;=D68.4^^131^1680^1
 ;;^UTILITY(U,$J,358.3,33828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33828,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,33828,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,33828,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,33829,0)
 ;;=D59.9^^131^1680^2
 ;;^UTILITY(U,$J,358.3,33829,1,0)
 ;;=^358.31IA^4^2
